The adjustment in price target by a prominent analyst like Chris Kotowski, while maintaining an Outperform rating, suggests a positive outlook on BAC's performance but with a slightly moderated expectation. This could lead to a neutral short-term impact on BAC's stock price as the market digests the minor adjustment in the price target.